Literature DB >> 23943901

Cost concerns of patients with cancer.

Tammy K Stump1, Naa Eghan, Brian L Egleston, Olivia Hamilton, Melanie Pirollo, J Sanford Schwartz, Katrina Armstrong, J Robert Beck, Neal J Meropol, Yu-Ning Wong.   

Abstract

PURPOSE: Health care providers are accustomed to identifying populations for whom cost-related concerns may be a significant barrier, such as the poor, but few empiric data have been collected to substantiate such assumptions, particularly among insured patients.
METHODS: Patients with cancer from academic and community hospitals completed a questionnaire that included closed-ended items concerning demographic variables, optimism, numeracy, and concerns about present and future medical costs. In addition, they answered open-ended questions regarding cost concerns and medical expenses.
RESULTS: Nearly all (99%) participants were insured. In response to the closed-ended questions, 30.3% of patients reported concern about paying for their cancer treatment, 22.3% reported that their family had made sacrifices to pay for their care, and 8.3% stated that their insurance adequately covered their current health care costs, and 17.3% reported concerns about coverage for their costs in the future. On open-ended questions, 35.3% reported additional expenses, and 47.5% reported concerns about health care costs. None of the assessed patient characteristics proved to be a robust predictor across all cost-related concerns. There was a strong association between the identification of concerns or expenses on the open-ended questions and concerns on closed-ended questions.
CONCLUSION: Cost concerns are common among patients with cancer who have health insurance. Health care providers may alleviate concerns by discussing cost-related concerns with all patients, not only those of lower socioeconomic status or those without insurance. A closed-ended screening question may help to initiate these conversations. This may identify potential resources, lower distress, and enable patients to make optimal treatment decisions.

Entities:  

Mesh:

Year:  2013        PMID: 23943901      PMCID: PMC3770507          DOI: 10.1200/JOP.2013.000929

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  16 in total

1.  The mediating role of appraisal and coping in the relationship between optimism-pessimism and quality of life.

Authors:  I Schou; Ø Ekeberg; C M Ruland
Journal:  Psychooncology       Date:  2005-09       Impact factor: 3.894

2.  SPIKE$: a six-step protocol for delivering bad news about the cost of medical care.

Authors:  Joshua McFarlane; Jerry Riggins; Thomas J Smith
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

3.  Numeracy and Medicare Part D: the importance of choice and literacy for numbers in optimizing decision making for Medicare's prescription drug program.

Authors:  Stacey Wood; Yaniv Hanoch; Andrew Barnes; Pi-Ju Liu; Janet Cummings; Chandrima Bhattacharya; Thomas Rice
Journal:  Psychol Aging       Date:  2011-06

4.  Impact of the cost of cancer treatment: an internet-based survey.

Authors:  Maurie Markman; Ryan Luce
Journal:  J Oncol Pract       Date:  2010-02-19       Impact factor: 3.840

Review 5.  Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.

Authors:  Deborah Schrag; Morgan Hanger
Journal:  J Clin Oncol       Date:  2007-01-10       Impact factor: 44.544

6.  Optimism, coping, and health: assessment and implications of generalized outcome expectancies.

Authors:  M F Scheier; C S Carver
Journal:  Health Psychol       Date:  1985       Impact factor: 4.267

7.  Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinoma.

Authors:  Kathrin Milbury; Nizar M Tannir; Lorenzo Cohen
Journal:  Ann Behav Med       Date:  2011-12

8.  Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.

Authors:  Veena Shankaran; Sanjay Jolly; David Blough; Scott D Ramsey
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

9.  Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting.

Authors:  Yu-Ning Wong; Brian L Egleston; Kush Sachdeva; Naa Eghan; Melanie Pirollo; Tammy K Stump; John Robert Beck; Katrina Armstrong; Jerome Sanford Schwartz; Neal J Meropol
Journal:  Med Care       Date:  2013-09       Impact factor: 2.983

10.  Measuring numeracy without a math test: development of the Subjective Numeracy Scale.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel; Aleksandra Jankovic; Holly A Derry; Dylan M Smith
Journal:  Med Decis Making       Date:  2007-07-19       Impact factor: 2.583

View more
  30 in total

1.  Multiple Stakeholder Perspectives on Cancer Stigma in North India.

Authors:  Adyya Gupta; Preet K Dhillon; Jyotsna Govil; Dipika Bumb; Subhojit Dey; Suneeta Krishnan
Journal:  Asian Pac J Cancer Prev       Date:  2015

2.  Communication with Physicians about Health Care Costs: Survey of an Insured Population.

Authors:  Nora B Henrikson; Eva Chang; Kevin Ulrich; Deborah King; Melissa L Anderson
Journal:  Perm J       Date:  2017

3.  Recognizing the Financial Burden of Cancer Patients in Clinical Trials.

Authors:  Ryan D Nipp; Elizabeth Powell; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2015-05-18

4.  Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer?

Authors:  Maria Pisu; Kelly M Kenzik; Robert A Oster; Patricia Drentea; Kimlin T Ashing; Mona Fouad; Michelle Y Martin
Journal:  Cancer       Date:  2015-01-06       Impact factor: 6.860

5.  Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer.

Authors:  Caitlin R Meeker; Daniel M Geynisman; Brian L Egleston; Michael J Hall; Karen Y Mechanic; Marijo Bilusic; Elizabeth R Plimack; Lainie P Martin; Margaret von Mehren; Bianca Lewis; Yu-Ning Wong
Journal:  J Oncol Pract       Date:  2016-06-21       Impact factor: 3.840

6.  The social and economic toll of cancer survivorship: a complex web of financial sacrifice.

Authors:  Matthew P Banegas; Jennifer L Schneider; Alison J Firemark; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Alexandra M Varga; Lisa A Waiwaiole; Stephanie M Nutt; Aditi Narayan; K Robin Yabroff
Journal:  J Cancer Surviv       Date:  2019-05-23       Impact factor: 4.442

7.  Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study.

Authors:  Sophia K Smith; Jonathan Nicolla; S Yousuf Zafar
Journal:  J Oncol Pract       Date:  2014-05-27       Impact factor: 3.840

Review 8.  A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can't Pay the Co-Pay.

Authors:  Louisa G Gordon; Katharina M D Merollini; Anthony Lowe; Raymond J Chan
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

Review 9.  Financial toxicity and implications for cancer care in the era of molecular and immune therapies.

Authors:  George Tran; S Yousuf Zafar
Journal:  Ann Transl Med       Date:  2018-05

10.  Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Authors:  Ryan D Nipp; Hang Lee; Elizabeth Powell; Nicole E Birrer; Emily Poles; Daniel Finkelstein; Karen Winkfield; Sanja Percac-Lima; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2016-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.